Maharashtra Reports First Death Due To Guillain-Barre Syndrome …
4 hours ago · The first death due to the Guillain Barre Syndrome (GBS) virus was reported in Solapur, Maharashtra amid the outbreak on Monday. Till now, 101 cases of Guillain-Barre …
RSV Vaccine Labeling Updated With Guillain-Barré Syndrome …
5 days ago · The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning …
RSV Vaccines Will Carry Warning for Guillain-Barré Syndrome
4 days ago · The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased risk for Guillain-Barré Syndrome (GBS) within 42 days …
Guillain-Barre Patients See Hope in New Potential Treatment - WebMD
Jul 31, 2024 · Results from a pivotal phase III randomized, placebo-controlled trial found that patients who took a one-time, low-dose IV of the drug were 2.4 times more likely to be in a …
Guillain-Barre syndrome 'more common than ... - Associated Press News
May 30, 2024 · An estimated 3,000 to 6,000 people develop Guillain-Barre syndrome in the U.S. each year — either after being infected by a virus or linked to a vaccination — and it’s more …
Risk of Guillain-Barre syndrome 6 times higher after COVID
Oct 18, 2023 · A new study from Israel ties COVID-19 infection to an increased risk of a diagnosis of Guillain-Barre syndrome (GBS) within 6 weeks, while mRNA vaccination was linked to a …
Study shows slight increase in Guillain-Barre syndrome risk with ...
Jan 16, 2024 · Study investigates the link between COVID-19 vaccines and autoimmune/neurological diseases, focusing on Guillain-Barre syndrome (GBS) risks …
R.S.V. Vaccines May Slightly Increase Risk of Rare Neurological ...
Feb 29, 2024 · Vaccines for respiratory syncytial virus may have caused a few cases of Guillain-Barré syndrome, a rare neurological condition, federal health officials said on Thursday.
Promising Agent Significantly Improves Disability in GBS - Medscape
Jun 27, 2024 · MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with …
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV ...
Feb 24, 2023 · Guillain-Barre syndrome, or inflammatory neuropathy, is a rare disorder in which the body's immune system mistakenly attacks the nerves. Symptoms range from brief …